Chlamydia trachomatis is an important human pathogen. Research to develop a Chlamydia
vaccine has focused on the major outer membrane protein (MOMP). Determinants of this …

Major impediments to a Chlamydia vaccine lie in discovering T cell antigens and polarizing
adjuvants that stimulate protective immunity. We previously reported the discovery of three T …

Using a combination of affinity chromatography and tandem mass spectrometry, we recently
identified 8 MHC class II (IA b)-bound Chlamydia peptides eluted from dendritic cells (DCs) …

The ability to induce protection against a genital challenge was studied in BALB/c female
mice with three Chlamydia trachomatis mouse pneumonitis (MoPn) major outer membrane …

The antigenically variant Chlamydia trachomatis major outer membrane protein (MOMP) is a
target of antibody-mediated neutralization in vitro, and it is an important protein for designing …

Pmps (Polymorphic Membrane Proteins) are a group of membrane bound surface exposed
chlamydial proteins that have been characterized as autotransporter adhesins and are …

We reported that intranasal immunization of mice with recombinant major outer membrane
protein (MOMP) of Chlamydia trachomatis genetically fused with modified cholera toxin …

Monoclonal antibodies exhibiting Chlamydia trachomatis serovar specificity (serovar A, B-
Ba, or C) and serogroup specificity (B, intermediate, or C serogroup) were produced and …

A vaccine is likely the most effective strategy for controlling human chlamydial infections.
Recent studies have shown immunization with Chlamydia muridarum major outer …

Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen in the
World and there is a need for a vaccine. To enhance the immunogenicity of a vaccine …